Calton & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-823
Closed -$200K 415
2021
Q4
$200K Buy
+823
New +$180K 0.05% 350
2021
Q1
Sell
-1,308
Closed -$217K 436
2020
Q4
$217K Sell
1,308
-306
-19% -$49.8K 0.04% 348
2020
Q3
$267K Buy
+1,614
New +$248K 0.05% 251
2018
Q2
Sell
-5,247
Closed -$438K 399
2018
Q1
$438K Buy
5,247
+1,013
+24% +$79.8K 0.13% 172
2017
Q4
$328K Buy
+4,234
New +$291K 0.08% 227

Other funds holding ZTS

Calton & Associates's ZTS Position: Q1 2022 in Review

Calton & Associates sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 823 shares — an estimated $200K sold.

Calton & Associates first reported a position in ZTS in Q4 2017 and held it in 5 quarters. The position peaked at $438K in Q1 2018. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

  • Calton & Associates reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
  • Calton & Associates sold 823 Zoetis shares in Q1 2022, an estimated $200K.
  • Calton & Associates first reported a position in Zoetis in Q4 2017 and held it in 5 quarters.
  • Calton & Associates's Zoetis position peaked at $438K in Q1 2018.
  • 1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Calton & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.